Skip to main content

Research and resources

Reputable sources. Lived wisdom.

A library that puts peer-reviewed research and the essays of women living this next to each other. Filter by phase, region or kind to find what's actually for you.

Popular:

Filters

Phase

Talk to your doctor or specialist before changing treatment. Each article carries an Evidence A / B / C tag.

How to read this page →
Legend, evidence grades & region tagsShow

Evidence A / B / C

Evidence A

Strong: major guidelines, large randomized trials, or systematic reviews. Safe to act on.

Evidence B

Moderate: a solid trial or consistent observational studies. Worth considering, with nuance.

Evidence C

Early or limited: small studies, mixed results, or expert opinion. Useful context, not a basis for big calls.

Region tags

Global

International bodies (WHO, IMS, Cochrane) or guidance that applies regardless of where you live.

Canada / US / UK

Country-specific guidelines, regulators, or clinical bodies (e.g. SOGC, NAMS, NICE).

Personal

Lived experience and essays. Not pinned to a country, these stories travel.

Filtering by region keeps personal stories visible so you don't lose voices when you narrow the clinical view.

Have a study or essay you think belongs here? Send it our way and a moderator will review it for the library.

Beyond Nila

Landmark papers and reference docs

The professional documents and journal pieces clinicians cite. Useful when you want to read the actual source behind the guidance.

  • Paper

    The [w]Health Employer Index 2026

    by Kearney (Paula Bellostas Muguerza, Anna Bode, Kate Maheu, Betty Pio)

    While most employers have taken initial steps on women's health, true maturity requires integrated action connecting policy to lived experience through better communication, data use, and employee feedback.

  • Paper

    Mega Menopause Survey 2025 / MM25

    by Menopause Mandate (with UCL support)

    15,000+ women across the UK on what menopause support actually looks like: what's improved, what's still missing, and where urgent change is needed. Patient-led data at a scale most clinical cohorts don't reach.

  • Paper

    Bridging the Gender Gap in Health Care Innovation: The Evolution of FemTech

    by Jenny Castillo Cato, MD, FACEP (JMIR)

    As FemTech matures into a $97B market, the priority must be deep, inclusive innovation that addresses chronic conditions and dismantles gender bias in research.

  • Paper

    The Veradigm 2026 Women's Health Report

    by Veradigm (Alina B., Isabelle Winer, Kate Cappell)

    With data from 148M+ patients, this report surfaces sobering gaps: from the surging adolescent mental health crisis to the fact that fewer than 1 in 10 eligible women receive HRT. A powerful call to bridge the evidence-to-practice gap.

  • Paper

    Global Fertility Report 2026

    by Emmeline Ventures (La Keisha Landrum Pierre, Azin Radsan van Alebeek, Blessing Chukwuneke)

    With 257 companies analyzed, this report highlights a stark funding gap: women founded nearly 60% of these firms, yet they receive only 32.5% of disclosed funding. Essential reading for understanding where venture capital is, and is not, placing its bets on reproductive health.

  • Paper

    The Persons Project: Breaking the Cycle

    by The Persons Project (a My Normative initiative)

    Synthesizes interviews with leaders across FemTech, academia, clinical research and life sciences to map the women's health knowledge gap, the vicious cycle of stagnation it creates, and a coordinated response: an open data ontology, shared research infrastructure, and an annual investment report.

  • Paper

    The 2022 Hormone Therapy Position Statement

    by The Menopause Society (NAMS)

    The current professional consensus document. Dense, but it's the thing your doctor's guidelines are based on.

  • Paper

    Vaginal estrogen use in breast cancer survivors

    by Crandall et al., Menopause (NAMS), 2017

    The reference clinicians cite when discussing local vaginal estrogen for GSM after breast cancer. Cross-link from /treatments/cancer-risk.

  • Paper

    ADHD, perimenopause and the case for clinical recognition

    by de Jong et al., 2023

    One of the first peer-reviewed pieces naming the pattern clinicians are now seeing in clinic.

  • Paper

    The Women's Health Innovation Radar (2026)

    by World Economic Forum, Kearney Health Institute, Gates Foundation, Wellcome Leap

    Maps where women's health innovation is actually happening across funding, evidence and product pipelines. Names menopause as under-resourced relative to disease burden.

No affiliate links. No paid placement. We update this shelf roughly every quarter.

Free for everyone, read smarter, not more

Three habits that turn 'I read a study' into 'I changed something.'

The internet has more menopause content than you can read in a lifetime. These three filters keep the noise out.

A randomized trial in The Lancet and a TikTok of someone's gut-feel are both 'studies' on Google. Knowing which is which is half the battle.

Try this week: Before you trust a claim, find the original. Look for: peer review, sample size, year, who funded it. If it's a single Instagram graphic with no link, close the tab.

Free for everyone, read smarter, not more

Three habits that turn 'I read a study' into 'I changed something.'

The internet has more menopause content than you can read in a lifetime. These three filters keep the noise out.

A randomized trial in The Lancet and a TikTok of someone's gut-feel are both 'studies' on Google. Knowing which is which is half the battle.

Try this week: Before you trust a claim, find the original. Look for: peer review, sample size, year, who funded it. If it's a single Instagram graphic with no link, close the tab.